Literature DB >> 21515270

Polycystic liver diseases: congenital disorders of cholangiocyte signaling.

Mario Strazzabosco1, Stefan Somlo.   

Abstract

Polycystic liver diseases (PLD) are inherited disorders of the biliary epithelium, caused by genetic defects in proteins associated with intracellular organelles, mainly the endoplasmic reticulum and the cilium. PLD are characterized by the formation and progressive enlargement of multiple cysts scattered throughout the liver parenchyma, and include different entities, classified based on their pathology, inheritance pattern, involvement of the kidney and clinical features. PLD should be considered as congenital diseases of cholangiocyte signaling. Here, we will review the changes in signaling pathways involved in liver cyst formation and progression, and their impact on cholangiocyte physiology. Each pathway represents a potential target for therapies aimed at reducing disease progression.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21515270      PMCID: PMC3109236          DOI: 10.1053/j.gastro.2011.04.030

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Mutations in SEC63 cause autosomal dominant polycystic liver disease.

Authors:  Sonia Davila; Laszlo Furu; Ali G Gharavi; Xin Tian; Tamehito Onoe; Qi Qian; Airong Li; Yiqiang Cai; Patrick S Kamath; Bernard F King; Pablo J Azurmendi; Pia Tahvanainen; Helena Kääriäinen; Krister Höckerstedt; Olivier Devuyst; Yves Pirson; Rodolfo S Martin; Richard P Lifton; Esa Tahvanainen; Vicente E Torres; Stefan Somlo
Journal:  Nat Genet       Date:  2004-05-09       Impact factor: 38.330

Review 2.  Medical and surgical treatment options for polycystic liver disease.

Authors:  Joost P H Drenth; Melissa Chrispijn; David M Nagorney; Patrick S Kamath; Vicente E Torres
Journal:  Hepatology       Date:  2010-12       Impact factor: 17.425

3.  Inhibition of Pkhd1 impairs tubulomorphogenesis of cultured IMCD cells.

Authors:  Weiyi Mai; Dong Chen; Tianbing Ding; Ingyu Kim; Sujun Park; Sae-youll Cho; Julia S F Chu; Dan Liang; Ning Wang; Dianqing Wu; Song Li; Ping Zhao; Roy Zent; Guanqing Wu
Journal:  Mol Biol Cell       Date:  2005-06-22       Impact factor: 4.138

4.  Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.

Authors:  Matthew T Nichols; Elsa Gidey; Tom Matzakos; Rolf Dahl; Greg Stiegmann; Raj J Shah; Jared J Grantham; J Gregory Fitz; R Brian Doctor
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

5.  Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.

Authors:  Joost P H Drenth; Rene H M te Morsche; Renate Smink; Juan S Bonifacino; Jan B M J Jansen
Journal:  Nat Genet       Date:  2003-02-10       Impact factor: 38.330

6.  Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat.

Authors:  Domenico Alvaro; Paolo Onori; Veronica Drudi Metalli; Gianluca Svegliati-Baroni; Franco Folli; Antonio Franchitto; Gianfranco Alpini; Maria Grazia Mancino; Adolfo Francesco Attili; Eugenio Gaudio
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

7.  ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.

Authors:  Carlo Spirli; Stefano Okolicsanyi; Romina Fiorotto; Luca Fabris; Massimiliano Cadamuro; Silvia Lecchi; Xin Tian; Stefan Somlo; Mario Strazzabosco
Journal:  Gastroenterology       Date:  2009-09-18       Impact factor: 22.682

8.  The transient receptor potential channels TRPP2 and TRPC1 form a heterotetramer with a 2:2 stoichiometry and an alternating subunit arrangement.

Authors:  Toshiro Kobori; Graham D Smith; Richard Sandford; J Michael Edwardson
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 9.  Pathophysiology of cholangiopathies.

Authors:  Mario Strazzabosco; Luca Fabris; Carlo Spirli
Journal:  J Clin Gastroenterol       Date:  2005-04       Impact factor: 3.062

Review 10.  The cholangiopathies: disorders of biliary epithelia.

Authors:  Konstantinos N Lazaridis; Mario Strazzabosco; Nicholas F Larusso
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

View more
  40 in total

1.  TGR5 in the Cholangiociliopathies.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 2.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

Review 3.  MicroRNAs and benign biliary tract diseases.

Authors:  Sergio A Gradilone; Steven P O'Hara; Tetyana V Masyuk; Maria Jose Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

4.  Somatic second-hit mutations leads to polycystic liver diseases.

Authors:  Jesús M Banales; Patricia Munoz-Garrido; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

5.  Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression.

Authors:  Tatyana V Masyuk; Seung-Ok Lee; Brynn N Radtke; Angela J Stroope; Bing Huang; Jesús M Banales; Anatoliy I Masyuk; Patrick L Splinter; Sergio A Gradilone; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2013-11-07       Impact factor: 4.307

6.  Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.

Authors:  Aura D Urribarri; Patricia Munoz-Garrido; María J Perugorria; Oihane Erice; Maite Merino-Azpitarte; Ander Arbelaiz; Elisa Lozano; Elizabeth Hijona; Raúl Jiménez-Agüero; Maite G Fernandez-Barrena; Juan P Jimeno; Marco Marzioni; Jose J G Marin; Tatyana V Masyuk; Nicholas F LaRusso; Jesús Prieto; Luis Bujanda; Jesús M Banales
Journal:  Gut       Date:  2014-01-16       Impact factor: 23.059

Review 7.  Therapeutic Targets in Polycystic Liver Disease.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

8.  Primary cilia disruption differentially affects the infiltrating and resident macrophage compartment in the liver.

Authors:  Kurt A Zimmerman; Cheng Jack Song; Nancy Gonzalez-Mize; Zhang Li; Bradley K Yoder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-15       Impact factor: 4.052

Review 9.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

10.  MicroRNAs in Cholangiopathies.

Authors:  Steven P O'Hara; Sergio A Gradilone; Tetyana V Masyuk; James H Tabibian; Nicholas F LaRusso
Journal:  Curr Pathobiol Rep       Date:  2014-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.